z-logo
open-access-imgOpen Access
A Review Literature on Efficacy and Comparison between the Drugs Used in Influenza
Author(s) -
Rabia Ashraf,
Hira Pervez,
Munis M Ahmed,
Fawad Ahmed,
Karun Neupane
Publication year - 2020
Publication title -
journal of nobel medical college
Language(s) - English
Resource type - Journals
eISSN - 2091-234X
pISSN - 2091-2331
DOI - 10.3126/jonmc.v9i1.29552
Subject(s) - medicine , pandemic , disease , intensive care medicine , limiting , covid-19 , infectious disease (medical specialty) , mechanical engineering , engineering
Seasonal flu or influenza is an acute respiratory illness caused by Influenza virus A and B. The disease is usually self-limiting, but can occasionally lead to dire complications. To prevent the occurrence of these complications, many preventive, as well as therapeutic remedies, have been implicated. Vaccines have shown to reduce morbidity associated with influenza viral infection. In addition to this, if an infection does occur, it may lead to adversities, especially in patients with extremes of ages, i.e., less than 12 and more than 65. The advent of anti-viral medications has helped in a significant reduction in the symptoms associated with this disease. But, as resistance to these chemicals has emerged, this is now contributing to the widespread endemics and pandemics. With this understanding, newer and better drugs are being introduced in the market. One such medication is Baloxavir, a modified version of the novel anti-viral drugs. We conducted a thorough electronic data search on PubMed and Google Scholar. Articles were filtered using the exclusion criteria of, “co-morbid conditions,” immunodeficiency state,” “Chronic Obstructive Pulmonary Disease,” etc. The extracted articles were within a five-year time frame and were free full text. Further information was extracted using cross-references. Articles were screened for duplication. In this literature review, we describe in detail the advantages of Baloxavir to reduce the morbidity associated with Influenza infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here